Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #8239
Reference
Drug alert 36/2024
Name
Drug Alert Class 4 Drug Alert 36 2024 – Class 4 medicines defect information – caution in use – Star Pharmaceuticals Ltd – Diflucan oral suspension 40mg/ml
Categories
Scottish Government
Drug Alerts
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
Scotland
Drugs
Safety
Risks
Pharmaceutical Industry
Medicines Recall
Description
Star Pharmaceuticals Limited has informed the MHRA that an error has been identified in the Patient Information Leaflet (PIL) for two batches of Diflucan Oral Suspension 40mg/ml. Section 6 of the PIL states “50mg of fluconazole per 5ml” instead of “200mg of fluconazole per 5ml”. The other sections of the PIL and product information state the correct strength of 200mg of fluconazole per 5ml.
Contact Name
Irene Fazakerley
Contact Email
Contact Address
Contact Phone
Created
2024-08-12 16:06:09
Click to go back to homepage